Google once believed it could use algorithms to track pandemics. People with flu would search for flu-related information, it reasoned, giving the tech giant instant knowledge of the disease’s prevalence. Google Flu Trends (GFT) would merge this information with flu tracking data to create algorithms that could predict the disease’s trajectory weeks before governments’ own estimates.
But after running the project for seven years, Google quietly abandoned it in 2015. It had failed spectacularly. In 2013, for instance, it miscalculated the peak of the flu season by 140 per cent.
According to the German psychologist Gerd Gigerenzer, this is a good example of the limitations of using algorithms to surveil and study society. The 74-year-old has just written a book on the subject, How to Stay Smart in a Smart World. He thinks humans need to remain in charge in a world increasingly filled with artificial intelligence that tries to replicate human thinking.
Technology
Browse the articles related to this topic below.
HEE is an executive non-departmental public body of DHSC, responsible for co-ordination of education and training within the health and public health workforce within England, including the training of doctors and nurses.
NHS Digital is a non-departmental public body responsible for the information, data and IT systems for commissioners, analysts and clinicians in health and social care in England.
NHSX is a joint unit of NHS England and DHSC, supporting local NHS and care organisations to digitise their services, connect the health and social care systems through technology and transform the way patients’ care is delivered at home, in the community and in hospital.
A power to enable formal legal mergers of DHSC’s arm’s length bodies is currently being considered by Parliament as part of the Health and Care Bill. The formal merger of HEE and NHSE/I is therefore subject to Parliament’s approval of that measure, expected in summer 2022.
NHS Digital and NHSX will form part of the new Transformation Directorate within NHSE alongside Improvement, and Innovation, Research and Life Sciences.
The NHSE/I Transformation Directorate will continue to lead the digital transformation agenda for the NHS and social care at national and ICS level.
NHSX will evolve into the strategy function of the Transformation Directorate.
NATO will adopt its first strategy on artificial intelligence and launch an innovation fund this week with the aim of investing $1 billion to “futureproof” the 30-nation security pact, Secretary-General Jens Stoltenberg said Wednesday.
…Stoltenberg said he expects the new NATO fund to invest in emerging and disruptive technologies. New headquarters and test centers will be set up in both Europe and North America to support the effort, he said.
Published: July 23, 2002
A draft government report says we will alter human evolution within 20 years by combining what we know of nanotechnology, biotechnology, IT and cognitive sciences. The 405-page report sponsored by the US National Science Foundation and Commerce Department, Converging Technologies for Improving Human Performance, calls for a broad-based research program to improve human performance leading to telepathy, machine-to-human communication, amplified personal sensory devices and enhanced intellectual capacity.
Our government has used Covid as an excuse to turn Australians into digital products. It is the perfect scam. Every dictatorship knows that humans are cheap, renewable, and disposable. Our digital identities are worth a fortune to the right third-party buyer, while the ability to track and control our movements presents a unique opportunity for politicians wishing to manage democracy instead of being a victim of its whims.
How is the Davos World Economic Forum involved in the coronavirus pandemic?
The Davos World Economic Forum (WEF) is a premier forum for governments, global corporations and international entrepreneurs. Founded in 1971 by engineer and economist Klaus Schwab, the WEF describes its mission as “shaping global, regional and industry agendas” and “improving the state of the world”. According to its website, “moral and intellectual integrity is at the heart of everything it does.”
Investigative journalist Whitney Webb joins [Catherine Austin Fitts] to discuss her latest excellent exposés of the high-tech push for central control.
Article from 24 Mar 2016
Researchers in the United States have developed a new method for controlling the brain circuits associated with complex animal behaviours, using genetic engineering to create a magnetised protein that activates specific groups of nerve cells from a distance.
The world’s richest medical research foundation, the Wellcome Trust, has teamed up with a pair of former DARPA directors who built Silicon Valley’s skunkworks to usher in an age of nightmarish surveillance, including for babies as young as three months old. Their agenda can only advance if we allow it.
https://unlimitedhangout.com/2021/06/investigative-reports/a-leap-toward-humanitys-destruction/
Published 14 Dec 2020
Nanobiotechnology is emerging very promising to investigate novel methodologies for managing COVID-19 pandemic/endemic successfully. In this direction, experts have explored the opto-electro-magnetic nanosystem to detect the SARS-CoV-2 virus using a biosensing approach. Such optical, electrical, or magnetic biosensors function based on geno-sensing and immune-sensing has detected the SARS-CoV-2 virus selectively at a very low level. These efficient-miniaturized biosensors can be operated using a smartphone and promoted for clinical application for early-stage diagnostics of COVID-19 infection. The successful integration of these SARS-CoV-2 virus sensors with AI and IoMT enables virus detection at point-of-location and sharing of bioinformatics with the medical center at the same time for timely therapeutics decision. This approach is also useful for tracking tasks and managing COVID-19 infection according to patient infection profiling. To avoid human-to-human SARS-CoV-2 virus transmission, experts have developed stimuli-responsive nanotechnology enable which can not only trap aerosol of virus size but can eradicate viruses on applying external stimulation for example nanoenable photo-sensitive virus degradation. Various types of clothes containing nanoparticles have demonstrated SARS-CoV-2 virus trapping and eradication successfully [2,9]. However, significant attention is required to increase the production and distribution of these masks for public use.
https://www.tandfonline.com/doi/full/10.1080/17425247.2021.1860938
The use of graphene-based materials in pharmaceutical nanotechnology has recently received more attention due to their unique chemical structure and physicochemical properties—including an ultra-high surface area, optical, thermal and electrical conductivities, and a good biocompatibility.
GO nanosheets tend to be hydrophilic and the surface contains reactive groups for an increased functionality or for loading drugs through covalent and non-covalent interactions. In addition, graphene-based nanomaterials can also be functionalized with diagnostic probes that have fluorescent and/or luminescent properties and can target ligands such as proteins, peptides, nucleic acids, antibodies, lipids, carbohydrates and folic acid.
In pharmaceutical applications, graphene-based nanomaterials possess a lot of potential for improving drug circulation times, in target drug and gene delivery systems, for acting as therapeutic agents and diagnostic tools, as well as graphene nanotheranostic agents that combine both diagnostic and therapy approaches in a single system.
The use of graphene-based materials in pharmaceutical nanotechnology has recently received more attention due to their unique chemical structure and physicochemical properties—including an ultra-high surface area, optical, thermal and electrical conductivities, and a good biocompatibility.
GO nanosheets tend to be hydrophilic and the surface contains reactive groups for an increased functionality or for loading drugs through covalent and non-covalent interactions. In addition, graphene-based nanomaterials can also be functionalized with diagnostic probes that have fluorescent and/or luminescent properties and can target ligands such as proteins, peptides, nucleic acids, antibodies, lipids, carbohydrates and folic acid.
In pharmaceutical applications, graphene-based nanomaterials possess a lot of potential for improving drug circulation times, in target drug and gene delivery systems, for acting as therapeutic agents and diagnostic tools, as well as graphene nanotheranostic agents that combine both diagnostic and therapy approaches in a single system.
The use of graphene-based materials in pharmaceutical nanotechnology has recently received more attention due to their unique chemical structure and physicochemical properties—including an ultra-high surface area, optical, thermal and electrical conductivities, and a good biocompatibility.
GO nanosheets tend to be hydrophilic and the surface contains reactive groups for an increased functionality or for loading drugs through covalent and non-covalent interactions. In addition, graphene-based nanomaterials can also be functionalized with diagnostic probes that have fluorescent and/or luminescent properties and can target ligands such as proteins, peptides, nucleic acids, antibodies, lipids, carbohydrates and folic acid.
In pharmaceutical applications, graphene-based nanomaterials possess a lot of potential for improving drug circulation times, in target drug and gene delivery systems, for acting as therapeutic agents and diagnostic tools, as well as graphene nanotheranostic agents that combine both diagnostic and therapy approaches in a single system.
The use of graphene-based materials in pharmaceutical nanotechnology has recently received more attention due to their unique chemical structure and physicochemical properties—including an ultra-high surface area, optical, thermal and electrical conductivities, and a good biocompatibility.
GO nanosheets tend to be hydrophilic and the surface contains reactive groups for an increased functionality or for loading drugs through covalent and non-covalent interactions. In addition, graphene-based nanomaterials can also be functionalized with diagnostic probes that have fluorescent and/or luminescent properties and can target ligands such as proteins, peptides, nucleic acids, antibodies, lipids, carbohydrates and folic acid.
In pharmaceutical applications, graphene-based nanomaterials possess a lot of potential for improving drug circulation times, in target drug and gene delivery systems, for acting as therapeutic agents and diagnostic tools, as well as graphene nanotheranostic agents that combine both diagnostic and therapy approaches in a single system.
An international team of researchers has developed a drug delivery technique that utilizes graphene strips as “flying carpets” to deliver two anticancer drugs sequentially to cancer cells, with each drug targeting the distinct part of the cell where it will be most effective. The technique was found to perform better than either drug in isolation when tested in a mouse model targeting a human lung cancer tumor.
https://web.archive.org/web/20220403192812/https://www.nanowerk.com/what_is_graphene.php
Keynote by Dennis Bushnell, Chief Scientist, NASA Langley on the major issues facing humans & society indicating where water fits in and explicating the water solution spaces and potential silver bullets, including Frontier/ Revolutionary energetics, advanced nano-technology and the use of salt loving plants, Halophytes, for Global Food Production.
Rob Verkerk, Founder, Executive and Scientific Director of the Alliance for Natural Health International, a scientist who has for 30 years been exploring positive ways to span the gulfs between science and the law, between academia and industry, and between governments and their people.
Backup mirror:
In a first, India has demonstrated an offensive swarm drone system that simulated taking down a range of targets, ranging from tanks, terror camps, helipads and fuel dumps at the annual Army Day parade in the capital.
The demonstration, which consisted of 75 drones working autonomously to identify and take down targets with Kamikaze missions, is an early peek into future technology being developed by the Army in partnership with the private industry.
Ensuring everyone has a legal identity, including birth registration, by 2030 is one of the United Nations’ Sustainable Development Goals (SDGs). It prompted the World Bank to launch its Identification for Development (ID4D) initiative in 2014.
The latest data from the Bank shows there are just over 987 million people in the world who have no legal identity, down from 1.5 billion in 2016. The majority live in low-income countries where almost 45% of women and 28% of men lack a legal ID.
…Thompson’s app uses blockchain to preserve the user’s digital identity from interference, making it accessible only to the person whose ID it holds. As a digital solution, it goes with the grain of how many people in emerging economies manage their finances using smartphones.
Categories
The future of citizen data systems – GOV.UK
Citizen data is growing rapidly in volume and variety, and is increasingly internationally mobile. This has the potential to bring huge benefits to the economy and society, but also increased risks.
This report examines different approaches to the governance, control and use of citizen data across the world. It aims to inform public debate and government decisions with an international, whole-system view of citizen data. Variations in regional data systems both reflect and determine developments in the economy, security and society.
Controlling movement in these tiny machines requires the researchers to shine a laser on minuscule light-sensitive circuits on their backs, which propels their four legs forward. They’ve been designed to operate in all manner of environments such as extreme acidity and temperatures. One of their chief purposes, the researchers say, could be to investigate the human body from the inside.
Fifty years of Moore’s law scaling in microelectronics have brought remarkable opportunities for the rapidly evolving field of microscopic robotics. Electronic, magnetic and optical systems now offer an unprecedented combination of complexity, small size and low cost, and could be readily appropriated for robots that are smaller than the resolution limit of human vision (less than a hundred micrometres). However, a major roadblock exists: there is no micrometre-scale actuator system that seamlessly integrates with semiconductor processing and responds to standard electronic control signals. Here we overcome this barrier by developing a new class of voltage-controllable electrochemical actuators that operate at low voltages (200 microvolts), low power (10 nanowatts) and are completely compatible with silicon processing. To demonstrate their potential, we develop lithographic fabrication-and-release protocols to prototype sub-hundred-micrometre walking robots. Every step in this process is performed in parallel, allowing us to produce over one million robots per four-inch wafer. These results are an important advance towards mass-manufactured, silicon-based, functional robots that are too small to be resolved by the naked eye.